Clinical Trial Update: Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 double-blind randomized trial of Bicifadine SR for chronic neuropathic pain due to diabetes (Diabetic Peripheral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Bicifadine SR (bicifadine)

Snippet

Sponsor: XTL Biopharmaceuticals | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: UNKNOWN